<DOC>
	<DOCNO>NCT00837512</DOCNO>
	<brief_summary>The goal study determine microneedles effectively painlessly deliver insulin child young adult type 1 diabetes .</brief_summary>
	<brief_title>Insulin Delivery Using Microneedles Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>≥ 8 year age &lt; 19 year age Type 1 Diabetes least 2 year Uses conventional , FDAapproved insulin pump past year Uses Lispro insulin Mean hemoglobin A1C ≤ 8.5 % past year Body mass index ≤ 85th percentile age Understand willing adhere study protocol Type 2 Diabetes Acanthosis nigricans Clinically significant major organ system disease On glucocorticoid therapy Insulin requirement ≥ 150 U/day Illness day study Cognitive impairment ( IQ &lt; 85 &gt; 2 grade behind ageappropriate grade ) Pregnant breastfeeding ( female ) .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>microneedle continuous subcutaneous insulin infusion</keyword>
</DOC>